# Protective Effects of Neonatal Plasma in Ischemic Heart Disease

> **NIH NIH F31** · UNIVERSITY OF CALIFORNIA LOS ANGELES · 2020 · $25,315

## Abstract

PROJECT SUMMARY
It is well established that aging drives the impairment and degenerative processes of various organ systems
within the body. In the heart, age-related changes are important risk factors for ischemic heart disease, which is
the leading cause of morbidity and mortality in the United States. Recent studies have shown that circulating
factors found in young blood can partially reverse age-related loss of cognitive function, restore muscle
dysfunction, and improve strength and endurance exercise capacity. While much of the focus has been on the
neurological field, a recent report identified a single factor in the blood of a two month-old mouse capable of
reversing age-related cardiac hypertrophy. Interestingly, it is also clinically observed that pediatric patients are
able to restore baseline cardiac function after injury faster than in the aged population. Research from our
laboratory has demonstrated that systemic delivery of neonatal plasma into adult mice after ischemia-reperfusion
(I/R) injury offers protection from scar formation, improves cardiac function, and promotes vascular remodeling.
From these observations, we hypothesize that there exists “pro-youthful” factors in neonatal plasma that offer a
protective milieu and prevent irreversible myocardial damage. Thus, the overall goal of this proposal is to identify
pathway(s)/factor(s) found in neonatal plasma that may be the main drivers in improving cardiac function after
myocardial injury. We propose the following three aims: (1) determining a specific developmental period during
which “pro-youthful” factors are present in circulation and can mediate the protective effects observed, (2)
examining the proteomic profiles of neonatal and adult mouse plasma to identify differentially expressed proteins
and narrow down potential therapeutic candidates, and (3) determining gene expression changes of major
cardiac cell types in response to I/R injury treated with neonatal plasma. The success of the proposed project
could set the platform for therapeutic interventions to prevent the progression to heart failure after an acute
myocardial infarction, which would greatly relieve the financial and health burden that it holds worldwide.

## Key facts

- **NIH application ID:** 9994109
- **Project number:** 5F31HL144057-03
- **Recipient organization:** UNIVERSITY OF CALIFORNIA LOS ANGELES
- **Principal Investigator:** Ngoc Bao Nguyen
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $25,315
- **Award type:** 5
- **Project period:** 2018-09-30 → 2021-03-19

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9994109

## Citation

> US National Institutes of Health, RePORTER application 9994109, Protective Effects of Neonatal Plasma in Ischemic Heart Disease (5F31HL144057-03). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/9994109. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*